Efficacy and safety of gemigliptin/metformin initial combination therapy versus either as monotherapy in drug-naive patients with type 2 diabetes

被引：0

作者：

Lim, S. ^{[1
]}

Min, K. ^{[2
]}

Yu, J. -M. ^{[3
]}

Chamnan, P. ^{[4
]}

Kim, E. ^{[5
,13
]}

Yoon, K. -H. ^{[6
]}

Kwon, S. ^{[7
]}

Moon, M. ^{[8
]}

Lee, K. ^{[9
]}

Kim, D. -J. ^{[10
]}

Kim, M. ^{[11
]}

Wongtanate, M. ^{[12
]}

Kim, E. ^{[5
,13
]}

Kim, S. -H. ^{[13
]}

Lee, M. -K. ^{[14
]}

机构：

[1] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea

[2] Eulji Univ, Med Ctr, Seoul, South Korea

[3] Kangnam Sacred Heart Hosp, Seoul, South Korea

[4] Sunpasitthiprasong Hosp, Ubon Ratchathani, Thailand

[5] Ulsan Univ Hosp, Ulsan, South Korea

[6] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea

[7] Samsung Changwon Hosp, Chang Won, South Korea

[8] Seoul Natl Univ, Boramae Med Ctr, Seoul, South Korea

[9] Ajou Univ Hosp, Suwon, South Korea

[10] Inje Univ, Ilsan Paik Hosp, Goyang, South Korea

[11] Inje Univ, Haeundae Paik Hosp, Busan, South Korea

[12] Nan Hosp, Nan, Thailand

[13] LG Life Sci, Seoul, South Korea

[14] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea

来源：

DIABETOLOGIA | 2015年 / 58卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

109

引用

页码：S54 / S54

页数：1

共 50 条

[41] Efficacy and safety of initial combination of DPP-IV inhibitors and metformin versus metformin monotherapy in type 2 diabetes: a systematic review of randomized controlled trials
Gao, W.
Dong, J.
Liu, J.
Li, Y.
Liu, F.
Yang, L.
Zhou, X.
Liao, L.
DIABETES OBESITY & METABOLISM, 2014, 16 (02): : 179 - 185
[42] INITIAL combination therapy with vildagliptin/metformin in drug-naive Asian type 2 diabetes patients: influence of age, BMI and co-morbidities in a real world setting
Mirasol, R. C.
Pathan, M. F.
Chawla, M.
Kim, T. H.
Cooke, K.
Hours-Zesiger, P.
Shete, A.
DIABETOLOGIA, 2017, 60 : S355 - S355
[43] Association of the SLC47A1 Gene Variant With Responses to Metformin Monotherapy in Drug-naive Patients With Type 2 Diabetes
Kim, Hamin
Bae, Suhyun
Yoon, Ha Young
Yee, Jeong
Gwak, Hye Sun
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (09): : 2684 - 2690
[44] Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial
Lee, Jie-Eun
Yu, Seung Hee
Kim, Sung Rae
Ahn, Kyu Jeung
Song, Kee-Ho
Lee, In-Kyu
Shon, Ho-Sang
Kim, In Joo
Lim, Soo
Kim, Doo-Man
Chung, Choon Hee
Lee, Won-Young
Lee, Soon Hee
Kim, Dong Joon
Cho, Sung-Rae
Jung, Chang Hee
Jeon, Hyun Jeong
Lee, Seung-Hwan
Park, Keun-Young
Rhee, Sang Youl
Kim, Sin Gon
Park, Seok O.
Kim, Dae Jung
Kim, Byung Joon
Lee, Sang Ah
Kim, Yong-Hyun
Kim, Kyung-Soo
Seo, Ji A.
Nam-Goong, Il Seong
Lee, Chang Won
Kim, Duk Kyu
Kim, Sang Wook
Cho, Chung Gu
Kim, Jung Han
Kim, Yeo-Joo
Yoo, Jae-Myung
Min, Kyung Wan
Lee, Moon-Kyu
ACTA PEDIATRICA DE MEXICO, 2024, 48 (04):
[45] Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial
Lee, Jie-Eun
Yu, Seung Hee
Kim, Sung Rae
Ahn, Kyu Jeung
Song, Kee-Ho
Lee, In-Kyu
Shon, Ho-Sang
Kim, In Joo
Lim, Soo
Kim, Doo-Man
Chung, Choon Hee
Lee, Won-Young
Lee, Soon Hee
Kim, Dong Joon
Cho, Sung-Rae
Jung, Chang Hee
Jeon, Hyun Jeong
Lee, Seung-Hwan
Park, Keun-Young
Rhee, Sang Youl
Kim, Sin Gon
Park, Seok O.
Kim, Dae Jung
Kim, Byung Joon
Lee, Sang Ah
Kim, Yong-Hyun
Kim, Kyung-Soo
Seo, Ji A.
Nam-Goong, Il Seong
Lee, Chang Won
Kim, Duk Kyu
Kim, Sang Wook
Cho, Chung Gu
Kim, Jung Han
Kim, Yeo-Joo
Yoo, Jae-Myung
Min, Kyung Wan
Lee, Moon-Kyu
DIABETES & METABOLISM JOURNAL, 2024, 48 (04) : 730 - 739
[46] Efficacy and Safety of Gemigliptin Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone
Rhee, Eun Jung
Min, Kyung Wan
Jang, Hak Chul
Nam-Goong, Il Seong
Chung, Choon Hee
Park, Joong Yeol
Bae, Hak Yeon
Kim, Doo-Man
Baik, Sei Hyun
Lee, Moon-Kyu
Kim, Byung-Joon
Chang, Sang Ah
Ahn, Chul Woo
Kim, Yong Seong
Yoon, Kun Ho
Park, Kyong Soo
Kim, Hae Jin
Shivane, Vyankatesh K.
Sosale, Aravind R.
Dharmalingam, Mala
Gandhi, Pramod
Gupta, Sandeep Kumar
Pitale, Shailesh
Agarwal, Pankaj Kumar
Rais, Nadeem
Mohan, V.
Mahesh, Uma
Kim, Jeong Ae
Kim, Pan Kyung
Kim, Sun Woo
DIABETES, 2012, 61 : A291 - A291
[47] Efficacy and safety of gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
Rhee, E. J.
Min, K. W.
Jang, H. C.
Chung, C. H.
Nam-Goong, I. S.
Bae, H. Y.
Lee, M. K.
Baik, S. H.
Shivane, V. K.
Sosale, A. R.
Dharmalingam, M.
Gandhi, P.
Gupta, S. K.
Kim, J. A.
Kim, S. W.
DIABETOLOGIA, 2012, 55 : S352 - S352
[48] Saxagliptin improves glycaemic control either as add-on therapy to metformin or as initial combination therapy with metformin in patients with type 2 diabetes
Pfuetzner, A.
Gurieva, I
Antsiferov, M.
Allen, E.
Ravichandran, S.
Chen, R.
SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 168S - 169S
[49] Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study
Williams-Herman, Debora
Johnson, Jeremy
Teng, Rujun
Luo, Edmund
Davies, Michael J.
Kaufman, Keith D.
Goldstein, Barry J.
Amatruda, John M.
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (03) : 569 - 583
[50] Safety and efficacy of sitagliptin and metformin when used as initial combination therapy to treat hyperglycaemia in patients with type 2 diabetes
不详
DIABETES OBESITY & METABOLISM, 2008, 10 (01): : 97 - 97

← 1 2 3 4 5 →